Skip to content
healthcare.dev
Get a free key

AMTAGVI

NDC 73776-001, lifileucel, suspension, from Iovance Biotherapeutics Inc..

Product NDC
73776-001
Status
Listed
Labeler
Iovance Biotherapeutics Inc.
Dosage form
SUSPENSION
Route
INTRAVENOUS
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125773
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73776-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIFILEUCEL72000000000 1/500mL
Package NDCNDC-11Package
73776-001-12737760001121 BAG in 1 CARTRIDGE (73776-001-12) / 125 mL in 1 BAG (73776-001-11)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 73776-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73776-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73776-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.